期刊文献+

初步建立中国人前列腺癌预测的数学模型 被引量:5

Development of a Nomogram for Predicting Positive Initial Prostate Biopsy Among Chinese Patients
下载PDF
导出
摘要 目的建立中国人前列腺癌预测模型。方法对556例疑似前列腺癌患者行前列腺穿刺活检,收集建立模型的变量:患者年龄、前列腺体积、前列腺特异性抗原(PSA)、游离PSA(f-PSA)/总PSA(t-PSA)。将变量通过逐步回归建立回归方程,在此基础上建立穿刺活检阳性的危险评分数学模型,并通过受试者工作曲线下面积来评估该模型的预测价值。结果 556例患者中,205例(36.87%)经前列腺穿刺活检证实为前列腺癌。单因素分析结果显示,患者的年龄、前列腺体积、血清PSA、f-PSA/t-PSA均为建立数学模型的影响因素。对受试者工作曲线的分析结果显示,所建模型的曲线下面积为0.8767,大于患者年龄、前列腺体积、PSA、f-PSA/t-PSA等单因素的0.6397、0.7255、0.7111、0.6973。结论初步建立具有较高预测价值的前列腺癌预测模型。 Objective To develop a predictive nomogram for predicting the prostate carcinoma among Chinese population.Methods Totally 556 Chinese male patients who had undergone an initial prostate biopsy in our hospital from July 2004 to February 2009 were enrolled in this study.Variables including age,volume,prostate specific antigen(PSA) level,and free PSA(f-PSA)/total PSA(t-PSA) were collected.Logistic regression analysis was performed to estimate the relative risk.Regression equation was established for variables via stepwise regression,via which a nomogram for assessing the positive biopsy results was established,and then the predictive value of this nomogram was evaluated using receiver area under curve(ROC) analysis.Results Of these 556 patients,cancer was detected in 205 patients(36.87%) via biopsies.Univariate analysis showed that age,prostate volume,PSA levels,and f-PSA/t-PSA were the influencing factors of the nomogram.The risk model performed well in an independent sample,with an AUCROC of 0.8767,which was significantly larger than that of the prediction based on age(AUCROC: 0.6397),prostate volume(AUCROC: 0.7255),PSA(AUCROC: 0.7111),or f-PSA/t-PSA(AUCROC: 0.6973) alone.Conclusion A preliminary nomogramwith high predictive value for Chinese population was successfully established.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2011年第6期685-688,共4页 Acta Academiae Medicinae Sinicae
基金 中国人民解放军总医院博士研究生创新项目(10BCZ02) 国家科技支撑计划项目(2009BAI86B05)~~
关键词 前列腺癌 数学模型 中国人 超声 前列腺特异性抗原 prostate carcinoma nomogram Chinese ultrasound prostate specific antigen
  • 相关文献

参考文献9

  • 1Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008[J].CA Cancer J Clin 2008,58(2):71-96.
  • 22006年上海市市区恶性肿瘤发病率[J].肿瘤,2009,29(9):918-918. 被引量:24
  • 3RochesterMA,Pashayan N,Matthews F,etal.Developmentand validation of risk score for predicting positive repeat pros-tate biopsy in patients with a previous negative biopsy in a UKpopulation[J].BMC Urol,2009,9:7.
  • 4Schr der FH,Hugosson J,Roobol MJ,et al.Screening andprostate-cancer mortality in a randomized European study[J].N Engl J Med,2009,360(13):1320-1328.
  • 5Ablin RJ,Haythorn MR.Screening for prostate cancer:Con-troversy?What controversy[J].Curr Oncol,2009,16(3):1-2.
  • 6Ohori M,Swindle P.Nomograms and instruments for the ini-tial prostate evaluation:the ability to estimate the likelihood ofidentifying prostate cancer[J].Semin Urol Oncol,2002,20(2):116-122.
  • 7Djavan B,Remzi M,Zlotta A,et al.Novel artificial neuralnetwork for early detection of prostate cancer[J].J Clin On-col,2002,20(4):921-929.
  • 8Presti JC Jr,O Dowd GJ,Miller MC,etal.Extended periph-eral zone biopsy schemes increase cancer detection rates andminimize variance in prostate specific antigen and age relatedcancer rates:results of a community multi-practice study[J].J Urol,2003,169(1):125-129.
  • 9Emiliozzi P,Scarpone P,DePaula F,et al.The incidence ofprostate cancer in men with prostate specific antigen greaterthan 4.0 ng/ml:a randomized study of 6 versus 12 coretransperineal prostate biopsy[J].J Urol,2004,171(1):197-199.

共引文献23

同被引文献47

  • 1张帆,黄毅,陆敏,马潞林.临床低危型前列腺癌根治性切除术后病理升级的危险因素分析[J].微创泌尿外科杂志,2013,2(4):280-283. 被引量:8
  • 2曹希亮,高江平,韩刚,唐杰,洪宝发.以前列腺特异抗原水平分组筛查与前列腺穿刺阳性率的关系[J].中华外科杂志,2006,44(6):372-375. 被引量:21
  • 3陈文彬.诊断学[M].北京:人民卫生出版社,2009:301-303.
  • 4Reis LO.Variations of serum testosterone levels in prostate cancer patients under LH-releasing hormone therapy,an open question[J].Endocr Relat Cancel, 2012,19 (3) : R93-R98.
  • 5Richardson TD,Oesterling JE.Age-specific reference ranges for serum prostate-specific antigen[J].Urol Clin North Am, 1997,24(2) :339-351.
  • 6Kawai M,Okajima K,Kobayashi K,et al.Combined use of PSA density and free to total PSA ratio for cancer detec- tion from patients with PSA elevations[J].Hinyokika Kiyo, 2006,52(2) : 113-117.
  • 7Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008[J] CA Cancer J Clin,2008,58(2) :71-96.
  • 8Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009[J] CA Cancer J Clin.,2009,59(4):225-249.
  • 9Pontes JE,Jabalameli P,Monfie J,et al.Prognostic impli-cations of disappearance rate of biologic markers following radical prostatectomy[J].Urology, 1990,36(5) :415-419.
  • 10Djavan B,Zlotta A,Kratzik C,et ol. PSA,PSA density,PSA- density of transition zone,free/total PSA ratio,and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4 ng/ml[J].Urology, 1999,54(3): 517-522.

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部